Multiple Myeloma and CAR T: Does It Work?

Medical researcher — Getty Images/sanjeri

If you’ve heard about chimeric antigen receptor (CAR T) t-cell therapy, a type of immunotherapy used to treat multiple myeloma, you may be wondering how it works. Learn about CAR T-cell therapy, the logistics involved, and whether it’s right for you.

Multiple Myeloma

CAR T-Cell Therapy for Myeloma: 9 Facts

Medically Reviewed: David Dingli, MD, PhD, FRCP

Discover nine facts about CAR-T cell therapy, how it works, and the mechanism it uses to help treat multiple myeloma.

Multiple Myeloma

CAR T-Cell Therapy for Myeloma: 9 Facts

Medically Reviewed: David Dingli, MD, PhD, FRCP

Discover nine facts about CAR-T cell therapy, how it works, and the mechanism it uses to help treat multiple myeloma.

Multiple Myeloma

CAR T-Cell Therapy for Multiple Myeloma: What to Know

Medically Reviewed: David Dingli, MD, PhD, FRCP

CAR T-cell therapy for multiple myeloma modifies T-cells to target BCMA on myeloma cells, offering precision and durable remission.

Multiple Myeloma

CAR T-Cell Therapy for Multiple Myeloma: What to Know

Medically Reviewed: David Dingli, MD, PhD, FRCP

CAR T-cell therapy for multiple myeloma modifies T-cells to target BCMA on myeloma cells, offering precision and durable remission.

Multiple Myeloma

CAR T vs. Stem Cell Transplant for Multiple Myeloma

Medically Reviewed: David Dingli, MD, PhD, FRCP

CAR T-cell therapy reprograms T-cells to target myeloma, while stem cell transplants replace damaged marrow after high-dose chemotherapy.

Multiple Myeloma

CAR T vs. Stem Cell Transplant for Multiple Myeloma

Medically Reviewed: David Dingli, MD, PhD, FRCP

CAR T-cell therapy reprograms T-cells to target myeloma, while stem cell transplants replace damaged marrow after high-dose chemotherapy.

Multiple Myeloma

CAR T: What to Expect at Your Appointments

Medically Reviewed: David Dingli, MD, PhD, FRCP

Check out this breakdown of what to expect, including several pre-treatment appointments, the actual CAR T infusion, and follow-up appointments.

Multiple Myeloma

CAR T: What to Expect at Your Appointments

Medically Reviewed: David Dingli, MD, PhD, FRCP

Check out this breakdown of what to expect, including several pre-treatment appointments, the actual CAR T infusion, and follow-up appointments.

Multiple Myeloma

CAR T Adverse Reactions: How to Prepare

Medically Reviewed: David Dingli, MD, PhD, FRCP

Blood cancer specialists share their insights on potential CAR T-cell therapy risks and what you can do to prepare.

Multiple Myeloma

CAR T Adverse Reactions: How to Prepare

Medically Reviewed: David Dingli, MD, PhD, FRCP

Blood cancer specialists share their insights on potential CAR T-cell therapy risks and what you can do to prepare.

Multiple Myeloma

CAR T: What Care Partners Need to Know

Medically Reviewed: David Dingli, MD, PhD, FRCP

Care partners may want to familiarize themselves with the following ten key facts before their loved one undergoes this treatment.

Multiple Myeloma

CAR T: What Care Partners Need to Know

Medically Reviewed: David Dingli, MD, PhD, FRCP

Care partners may want to familiarize themselves with the following ten key facts before their loved one undergoes this treatment.

Multiple Myeloma

How Data Supports CAR T in Pretreated Myeloma

While CAR T therapy is becoming more accessible, many question the data supporting its use. Here's what you should know about it in pretreated myeloma.

Multiple Myeloma

How Data Supports CAR T in Pretreated Myeloma

While CAR T therapy is becoming more accessible, many question the data supporting its use. Here's what you should know about it in pretreated myeloma.